Imatinib-induced decompensated heart failure in an elderly patient with chronic myeloid leukemia: case report and literature review

Because it is safe and well tolerated, imatinib is a standard first-line therapy for chronic myeloid leukemia (CML). Although there have been sporadic reports of imatinib-induced cardiotoxicity, including left ventricle (LV) dysfunction and heart failure, the evidence for it is contradictory. Here,...

Descripción completa

Detalles Bibliográficos
Autores principales: Ran, Hai-Hong, Zhang, Ran, Lu, Xue-Chun, Yang, Bo, Fan, Hui, Zhu, Hong-Li
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Science Press 2012
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545260/
https://www.ncbi.nlm.nih.gov/pubmed/23341847
http://dx.doi.org/10.3724/SP.J.1263.2012.05251

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3545260/
https://www.ncbi.nlm.nih.gov/pubmed/23341847
http://dx.doi.org/10.3724/SP.J.1263.2012.05251

Ejemplares similares